Globant (GLOB) Competitors

IQVIA (NYSE:IQV) and Globant (NYSE:GLOB) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation.

Do analysts prefer IQV or GLOB?

IQVIA currently has a consensus price target of $256.19, suggesting a potential upside of 30.28%. Globant has a consensus price target of $230.44, suggesting a potential upside of 1.55%. Given IQVIA's stronger consensus rating and higher probable upside, analysts clearly believe IQVIA is more favorable than Globant.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.90
Globant	1 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.67

Is IQV or GLOB more profitable?

IQVIA has a net margin of 9.17% compared to Globant's net margin of 7.20%. IQVIA's return on equity of 28.17% beat Globant's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	9.17%	28.17%	6.89%
Globant	7.20%	11.65%	7.88%

Does the MarketBeat Community prefer IQV or GLOB?

IQVIA received 284 more outperform votes than Globant when rated by MarketBeat users. Likewise, 68.29% of users gave IQVIA an outperform vote while only 60.06% of users gave Globant an outperform vote.

Company	Underperform	Outperform
IQVIA	Outperform Votes 672 68.29%	Underperform Votes 312 31.71%
Globant	Outperform Votes 388 60.06%	Underperform Votes 258 39.94%

Which has preferable earnings & valuation, IQV or GLOB?

IQVIA has higher revenue and earnings than Globant. IQVIA is trading at a lower price-to-earnings ratio than Globant, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$15.32B	2.33	$1.36B	$7.62	25.81
Globant	$2.35B	4.15	$158.54M	$3.83	59.25

Do institutionals and insiders hold more shares of IQV or GLOB?

89.6% of IQVIA shares are held by institutional investors. Comparatively, 91.6% of Globant shares are held by institutional investors. 1.6% of IQVIA shares are held by insiders. Comparatively, 2.7% of Globant shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has more risk & volatility, IQV or GLOB?

IQVIA has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500. Comparatively, Globant has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500.

Does the media favor IQV or GLOB?

In the previous week, IQVIA had 32 more articles in the media than Globant. MarketBeat recorded 45 mentions for IQVIA and 13 mentions for Globant. Globant's average media sentiment score of 0.91 beat IQVIA's score of 0.63 indicating that Globant is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	15 Very Positive mention(s)	7 Positive mention(s)	8 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive
Globant	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IQVIA beats Globant on 13 of the 19 factors compared between the two stocks.